文献速递神经肿瘤神经重症

脑膜瘤为主队列质子治疗后五年健康相关生活质量变化:前瞻性研究

Five-year changes in health-related quality of life after proton therapy in a primarily meningioma cohort: a prospective study.
PubMed 文献 · J Neurooncol · 2026-08-21

该前瞻性队列研究纳入126例接受质子束治疗(PBT)的成人良性颅内及鞍区肿瘤患者(以脑膜瘤为主),采用EORTC QLQ-C30和QLQ-BN20问卷从基线随访至5年。

要点

  • 质子治疗后5年整体健康状况稳定,但总体健康相关生活质量轻度下降。
  • 疲劳和失眠出现临床意义恶化,需纳入长期随访与康复计划。
  • 脱发增加达临床意义程度,头痛减轻,部分脑肿瘤特异症状加重。

核心结论

  • 质子束治疗后5年呈现混合模式:整体健康状况稳定,但总体健康相关生活质量轻度下降,多个症状和功能域恶化。
  • 疲劳和失眠出现临床意义增加,支持结构化长期随访和康复。
  • 这些结果反映质子束治疗后的长期结局,但治疗特异性贡献仍不确定。

研究设计与样本

  • 前瞻性队列研究,纳入126例接受质子束治疗的成人良性颅内及鞍区肿瘤患者(以脑膜瘤为主)。
  • 使用EORTC QLQ-C30和QLQ-BN20问卷从基线评估至5年。
  • 采用重复测量混合模型估计平均评分及相对基线的变化(95%CI),基线至5年变化分析纳入两个时间点均有数据的参与者。

主要发现

  • 整体健康状况无显著变化,QLQ-C30汇总评分轻度下降。
  • 疲劳和失眠出现临床意义恶化,疼痛、呼吸困难及便秘轻度增加。
  • 躯体功能和认知功能下降,情感功能改善。
  • QLQ-BN20显示脱发增加达临床意义程度,嗜睡、膀胱控制困难、运动功能障碍、交流缺陷及下肢无力加重,头痛减轻。

关键数值与推荐

  • 未观察所研究的社会人口学因素与疲劳或失眠变化之间的关联。

临床怎么用

  • 对质子束治疗后的良性颅内肿瘤患者应进行结构化长期随访,重点关注疲劳、失眠及功能下降。
  • 针对疲劳、失眠和躯体认知功能下降可考虑康复干预。

局限性

  • 仅61%参与者完成5年评估,存在失访偏倚可能。
  • 治疗特异性贡献仍不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Long-term patient-reported outcomes after Proton beam therapy (PBT) remain insufficiently described for patients with benign intracranial and seller-region tumors. The aim of this study was to evaluate health-related quality of life (HRQoL) and brain tumor-specific symptoms over five years after PBT in a primarily meningioma cohort. METHODS: In this prospective cohort study, adults treated with PBT completed the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-BN20 questionnaires from baseline through 5 years. Mixed models for repeated measures estimated mean scores and change from baseline with 95% confidence intervals. Baseline-to-five-year change analyses included participants with available data at both time points. Exploratory analyses evaluated associations between sociodemographic factors and changes over five-years. RESULTS: Seventy-seven of 126 participants (61%) completed the 5-year assessment. Global health status did not change significantly, whereas the QLQ-C30 summary score declined modestly. Clinically meaningful worsening was observed for fatigue and insomnia, with smaller increases in pain, dyspnoea, and constipation. Physical and cognitive functioning declined, while emotional functioning improved. On the QLQ-BN20, hair loss increased to a clinically meaningful extent and drowsiness, bladder control difficulties, motor dysfunction, communication deficits, and leg weakness worsened, whereas headaches decreased. No associations were observed between the investigated sociodemographic factors and change in fatigue or insomnia. CONCLUSIONS: Five-year outcomes demonstrated a mixed pattern with stable global health status despite a modest decline in overall HROoL and worsening in several symptom and functioning domains. Clinically meaningful increases in fatigue and insomnia, alongside smaller functional and brain tumor-specific changes, support structured long-term follow-up and rehabilitation. These findings reflect long-term outcomes following PBT, while treatment-specific contribution remains uncertain.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Fessé P, Åkeflo L, Ahlberg K, et al. Five-year changes in health-related quality of life after proton therapy in a primarily meningioma cohort: a prospective study. J Neurooncol. 2026. PMID: 42629514. doi:10.1007/s11060-026-05767-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。